Cargando…
In Situ Conversion of Melanoma Lesions into Autologous Vaccine by Intratumoral Injections of α-gal Glycolipids
Autologous melanoma associated antigens (MAA) on murine melanoma cells can elicit a protective anti-tumor immune response following a variety of vaccine strategies. Most require effective uptake by antigen presenting cells (APC). APC transport and process internalized MAA for activation of anti-tumo...
Autores principales: | Galili, Uri, Albertini, Mark R., Sondel, Paul M., Wigglesworth, Kim, Sullivan, Mary, Whalen, Giles F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3475649/ https://www.ncbi.nlm.nih.gov/pubmed/23087817 http://dx.doi.org/10.3390/cancers2020773 |
Ejemplares similares
-
In situ conversion of tumors into autologous tumor-associated antigen vaccines by intratumoral injection of α-gal glycolipids
por: Galili, Uri
Publicado: (2013) -
Conversion of Tumors into Autologous Vaccines by Intratumoral Injection of α-Gal Glycolipids that Induce Anti-Gal/α-Gal Epitope Interaction
por: Galili, Uri
Publicado: (2011) -
AGI-134: a fully synthetic α-Gal glycolipid that converts tumors into in situ autologous vaccines, induces anti-tumor immunity and is synergistic with an anti-PD-1 antibody in mouse melanoma models
por: Shaw, Stephen M., et al.
Publicado: (2019) -
Biosynthesis of α-Gal Epitopes (Galα1-3Galβ1-4GlcNAc-R) and Their Unique Potential in Future α-Gal Therapies
por: Galili, Uri
Publicado: (2021) -
Acceleration of Wound Healing by α-gal Nanoparticles Interacting with the Natural Anti-Gal Antibody
por: Galili, Uri
Publicado: (2015)